--- title: "為什麼 Virax Biolabs (VRAX) 的股票在夜間成為熱門話題？" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/286858214.md" description: "Virax Biolabs (VRAX) 的股票在盤後交易中上漲了 17.36%，達到 0.28 美元，此前在日內交易中上漲了 53.09%。Armistice Capital 披露其在 VRAX 中持有 4.99% 的股份。該公司正在推進 ViraxImmune，旨在針對急性感染後綜合症。儘管市值為 479 萬美元，但 VRAX 的股票在過去一年中下跌了 78.04%，交易價格接近其 52 周低點 0.10 美元" datetime: "2026-05-19T05:09:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286858214.md) - [en](https://longbridge.com/en/news/286858214.md) - [zh-HK](https://longbridge.com/zh-HK/news/286858214.md) --- # 為什麼 Virax Biolabs (VRAX) 的股票在夜間成為熱門話題？ **Virax Biolabs Group Limited ( VRAX )** shares are trending on Tuesday. VRAX shares rose 17.36% to $0.28 in after-hours trading on Monday. The jump in the late trading session follows an intraday gain of 53.09%, closing the stock at $0.24, according to Benzinga Pro data. ## Armistice Capital Takes 4.99% Stake in VRAX On May 15, **Armistice Capital**, LLC, a New York-based hedge fund, filed a **Securities and Exchange Commission** disclosure revealing a 4.99% beneficial ownership stake of over 1 million ordinary shares. The fund was founded in 2012 by Managing Member **Steven Boyd**, who signed the filing. Last month, Virax Biolabs ( VRAX ) announced it is advancing **ViraxImmune**, a proprietary assay targeting post-acute infection syndromes including Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a space the company estimates carries a U.S. economic burden exceeding $25 billion. ## Trading Metrics, Technical Analysis Virax, an innovative biotechnology company, has a market capitalization of $4.79 million. Its stock has traded between a 52-week high of $1.18 and a 52-week low of $0.10. VRAX's Relative Strength Index (RSI) is 69.52. Over the past 12 months, the stock of the biotech has dropped 78.04%. Currently, VRAX is positioned at about 13% of the way up from its 52-week low to its high, meaning the stock is trading closer to its annual low. **Benzinga’s Edge Stock Rankings** indicate that VRAX has a negative price trend across all time frames.
_Photo Courtesy: Gorodenkoff on Shutterstock.com_ **Disclaimer:** This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. **Read Also: Bakkt (BKKT) Stock Jumps Over 16% After Hours: Here's Why The ICE-Backed Crypto Platform Is Trending Overnight** ### 相關股票 - [VRAX.US](https://longbridge.com/zh-HK/quote/VRAX.US.md) - [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md) - [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md) - [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md) - [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md) - [LABU.US](https://longbridge.com/zh-HK/quote/LABU.US.md) - [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md) - [BKKT.US](https://longbridge.com/zh-HK/quote/BKKT.US.md) - [BKKT+.US](https://longbridge.com/zh-HK/quote/BKKT+.US.md) ## 相關資訊與研究 - [巨生醫獲 SelectUSA 醫療科技組金牌 啟動美國 A 輪募資目標 1000 萬美元](https://longbridge.com/zh-HK/news/286905054.md) - [ADHD 用藥「利他能」缺貨...網友疑考季因素 食藥署：藥廠早通知控貨中](https://longbridge.com/zh-HK/news/286754700.md) - [鉅亨速報 - Factset 最新調查：碩騰 ZTS-US 的目標價調降至 117 元，幅度約 10%](https://longbridge.com/zh-HK/news/286769910.md) - [Radnor Capital Management LLC 持有西氏醫藥服務公司價值 165 萬美元的股票。$WST](https://longbridge.com/zh-HK/news/286893528.md) - [“搞錢”，才是 Revolution 千億神話密碼](https://longbridge.com/zh-HK/news/286888792.md)